Clinical benefit to programmed death-1 inhibition for...

  • Main
  • 2019 / 11
  • Clinical benefit to programmed death-1 inhibition for...

Clinical benefit to programmed death-1 inhibition for non-small-cell lung cancer is associated with higher blood eosinophil levels

Sibille, A., Henket, M., Corhay, J. L., Louis, R., Duysinx, B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Acta Oncologica
DOI:
10.1080/0284186x.2019.1695063
Date:
November, 2019
File:
PDF, 619 KB
english, 2019
Conversion to is in progress
Conversion to is failed